Company profile
Cosmos Health Inc.
NASDAQ: COSM · Healthcare · Medical - Pharmaceuticals
#403 of 1,422 Healthcare companies by revenue66th-percentile growth
EA Score
55CFH 51DQ 51GM 69SS 62
v0.1 · 65/100 weight · provisional
↑ disclosure history, growth stability · ↓ filing timeliness, return on equity
Methodology →Revenue TTM
$69.5M
Rev growth YoY (TTM)
+29.8%
Net income (FY)
-$19.1M
Employees
163
as of 2026-08-22
Market cap
$12.1M
as of 2026-08-22
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$65.3M$65.3M2025
Net income-$19.1M-$19.1M2025
Operating income-$16.7M-$16.7M2025
Total assets$65.5M$65.5M2025
Liabilities$47.1M$47.1M2025
Equity$18.4M$18.4M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Wholesale91%
Nutraceuticals and Pharmaceuticals7%
Pharma manufacturing3%
By geography
Not disclosed.
The read
What is Cosmos Health Inc.’s revenue?
Cosmos Health Inc. booked $65.3M in FY2025 revenue, growing 20% year over year — faster than most Healthcare companies we track, at a -29.3% net margin.
Peers · Healthcare
Exagen Inc.55CAytu BioPharma, Inc.53DEnanta Pharmaceuticals, Inc.55CConcord Medical Services Holdings Limited59CElectromed, Inc.80B+Nuvation Bio Inc.49DNeighbors
Cook →Key facts
CEOGrigorios Siokas
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersChicago, IL
ExchangeNASDAQ: COSM
Employees163
IPO date2010-07-23
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.